Alzheimer's Disease Multiple Intervention Trial - ADMIT

阿尔茨海默病多重干预试验 - ADMIT

基本信息

项目摘要

DESCRIPTION (provided by applicant): The proposed study builds on our findings from a previous clinical trial that demonstrated the effectiveness of collaborative care for older adults with Alzheimer's disease cared for in primary care practices. In the prior trial, we demonstrated that guideline-level medical care resulted in improved quality of care and improved behavioral and psychological symptoms over one year among patients and their caregivers. However, despite finding significant differences among study groups on Neuropsychiatric Inventory scores, we did not find a significant difference between groups in functional decline. Both study groups experienced a significant decline in function over 18 months. The current study proposes to test a home-based intervention specifically designed to slow the rate of functional decline among older adults with Alzheimer's disease. In addition to building on our past research, the study also builds from recently reported research which demonstrated the short-term efficacy of home-based occupational therapy interventions among older adults with dementia. These trials show that older adults with dementia, including Alzheimer's disease, can both participate in and benefit from occupational therapy-based interventions delivered in the home. The specific aim of this study is to conduct a two-year, randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention. We will test the primary hypothesis that subjects with Alzheimer's disease in the intervention group will have improved function at two years compared with the best practice primary care control group. PUBLIC HEALTH RELEVANCE: More than 4 million Americans suffer from Alzheimer's disease and even under optimistic scenarios of the effectiveness of new treatments, this number will triple over the next few decades. For this reason, effective approaches to providing longitudinal care in the community for this burgeoning population are urgently needed.
描述(由申请人提供):拟议的研究以我们先前的临床试验的发现为基础,该研究证明了对老年人患有在初级保健实践中受到关注的老年人的协作护理的有效性。在先前的试验中,我们证明了指南级的医疗护理可在患者及其护理人员的一年中提高护理质量,并改善了行为和心理症状。但是,尽管研究小组在神经精神库存评分方面存在显着差异,但我们没有发现在功能下降中组之间存在显着差异。两个研究小组在18个月内的功能均大幅下降。当前的研究建议测试一种基于家庭的干预措施,该干预措施专门设计,以减慢阿尔茨海默氏病老年人的功能下降速度。除了基于我们过去的研究,这项研究还基于最近报道的研究,该研究表明,家庭痴呆症老年人的家庭职业治疗干预措施的短期疗效。这些试验表明,包括阿尔茨海默氏病在内的痴呆症老年人都可以参与并受益于家庭提供的基于职业治疗的干预措施。这项研究的具体目的是进行两年,随机的,对照临床试验,以通过比较接受最佳实践的对照组与接受最佳初级保健以及基于家庭职业治疗的干预组的对照组进行比较,以改善患有阿尔茨海默氏病的老年人的功能。我们将测试主要假设,即与最佳实践初级保健对照组相比,干预组中患有阿尔茨海默氏病的受试者将在两年内提高功能。 公共卫生相关性:超过400万美国人患有阿尔茨海默氏病,即使在新疗法有效性的乐观情况下,这一数字将在未来几十年中三倍。因此,迫切需要在社区为社区提供纵向护理的有效方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER M CALLAHAN其他文献

CHRISTOPHER M CALLAHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER M CALLAHAN', 18)}}的其他基金

Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10687172
  • 财政年份:
    2021
  • 资助金额:
    $ 54.25万
  • 项目类别:
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10493394
  • 财政年份:
    2021
  • 资助金额:
    $ 54.25万
  • 项目类别:
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
  • 批准号:
    10340047
  • 财政年份:
    2021
  • 资助金额:
    $ 54.25万
  • 项目类别:
Training Core
培训核心
  • 批准号:
    10229434
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Training Core
培训核心
  • 批准号:
    10443680
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Training Core
培训核心
  • 批准号:
    10673680
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Brain Health Patient Safety Learning Laboratory
脑健康患者安全学习实验室
  • 批准号:
    9059908
  • 财政年份:
    2015
  • 资助金额:
    $ 54.25万
  • 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
  • 批准号:
    8293129
  • 财政年份:
    2010
  • 资助金额:
    $ 54.25万
  • 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
  • 批准号:
    7987916
  • 财政年份:
    2010
  • 资助金额:
    $ 54.25万
  • 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
  • 批准号:
    8494492
  • 财政年份:
    2010
  • 资助金额:
    $ 54.25万
  • 项目类别:

相似国自然基金

用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
  • 批准号:
    32301097
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
  • 批准号:
    82300739
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
  • 批准号:
    32371426
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
  • 批准号:
    82302221
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Healthcare use among older adults with dementia after large-scale disasters
大规模灾难后患有痴呆症的老年人的医疗保健使用情况
  • 批准号:
    10591812
  • 财政年份:
    2023
  • 资助金额:
    $ 54.25万
  • 项目类别:
ADRD spousal caregivers, loneliness, & immune dysregulation: Real-Time, real-world intervention targets
ADRD 配偶照顾者、孤独、
  • 批准号:
    10651524
  • 财政年份:
    2023
  • 资助金额:
    $ 54.25万
  • 项目类别:
Wicked Smart Pad: Washable Sensorized Bedding for the Prevention and Detection of Moisture Events
Wicked Smart Pad:可清洗的感应床上用品,用于预防和检测潮湿事件
  • 批准号:
    10601816
  • 财政年份:
    2023
  • 资助金额:
    $ 54.25万
  • 项目类别:
Resilient Together for Dementia: A live video resiliency dyadic intervention for persons with dementia and their care-partners early after diagnosis
Resilient Together for Dementia:针对痴呆症患者及其护理伙伴在诊断后早期进行的实时视频弹性二元干预
  • 批准号:
    10524823
  • 财政年份:
    2022
  • 资助金额:
    $ 54.25万
  • 项目类别:
Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention
急诊普通外科谵妄恢复模型:协作护理干预
  • 批准号:
    10416631
  • 财政年份:
    2022
  • 资助金额:
    $ 54.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了